50 related articles for article (PubMed ID: 35871474)
1. Current and prior human papillomavirus (HPV) type and cytology results enable risk assessment for triage to colposcopy.
Feldman S
BJOG; 2022 Dec; 129(13):2141. PubMed ID: 35871474
[No Abstract] [Full Text] [Related]
2. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of p16
Song F; Belinson JL; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
Gynecol Oncol; 2021 Aug; 162(2):322-330. PubMed ID: 34059349
[TBL] [Abstract][Full Text] [Related]
4. Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samples.
Leung SOA; Feldman S; Kalyanaraman R; Shanmugam V; Worley MJ; Berkowitz RS; Horowitz NS; Feltmate CM; Muto MG; Lee LJ; King MT; Einarsson JI; Ajao MO; Elias KM
Am J Reprod Immunol; 2021 Jul; 86(1):e13394. PubMed ID: 33501727
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Different HPV-based Strategies and Cytology in Routine Cervical Cancer Screening Programme in China: A Population-based Study.
Wang S; Li L; Yang J; Han N; Bao H; Wang HJ
Cancer Prev Res (Phila); 2022 Jan; 15(1):45-54. PubMed ID: 34556493
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
7. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
9. Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: A population-based study in rural China.
Zhao XL; Xu XQ; Duan XZ; Rezhake R; Hu SY; Wang Y; Xia CF; Zhang X; Qiao YL; Sankaranarayanan R; Zhao FH; Basu P
Int J Cancer; 2020 Sep; 147(5):1275-1285. PubMed ID: 31970767
[TBL] [Abstract][Full Text] [Related]
10. [Cervical cancer screning: from cytology to HPV testing].
Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
[TBL] [Abstract][Full Text] [Related]
11. Options for triage and implications for colposcopists within European HPV-based cervical screening programmes.
Leeson S; Alalade R; Singh N; Nieminen P; Cruickshank M; Carcopino X; Bergeron C
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():332-342. PubMed ID: 33524777
[TBL] [Abstract][Full Text] [Related]
12. Triage of Women Testing Positive With the careHPV Test on Self-Collected Vaginal Samples for Cervical Cancer Screening in a Low-Resource Setting.
Poli UR; Gowrishankar S; Swain M; Jeronimo J
J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241206
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.
Hanley SJB; Fujita H; Aoyama-Kikawa S; Kasamo M; Torigoe T; Matsuno Y; Noriaki S;
J Gynecol Oncol; 2021 Nov; 32(6):e86. PubMed ID: 34708593
[TBL] [Abstract][Full Text] [Related]
14. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
[TBL] [Abstract][Full Text] [Related]
15. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
[TBL] [Abstract][Full Text] [Related]
16. Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China.
Zhang J; Yang D; Cui X; Liu G; Cui Z; Wang C; Piao H
Front Cell Infect Microbiol; 2022; 12():935071. PubMed ID: 36105144
[TBL] [Abstract][Full Text] [Related]
17. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
18. A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.
Zorzi M; Frayle H; Rizzi M; Fedato C; Rugge M; Penon MG; Bertazzo A; Callegaro S; Campagnolo M; Ortu F; Del Mistro A;
BJOG; 2017 Sep; 124(10):1585-1593. PubMed ID: 28120382
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.
Benevolo M; Vocaturo A; Caraceni D; French D; Rosini S; Zappacosta R; Terrenato I; Ciccocioppo L; Frega A; Giorgi Rossi P
J Clin Microbiol; 2011 Jul; 49(7):2643-50. PubMed ID: 21525231
[TBL] [Abstract][Full Text] [Related]
20. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]